USE OF NOVEL ORAL ANTICOAGULANTS IN ADULT FONTAN PATIENTS

Authors :: Dhaval R. Parekh
Justin Georgekutty
Amir Kazerouninia
Peter R. Ermis
Wilson Lam
Wayne J. Franklin
Source :: Journal of the American College of Cardiology. 69:653
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Background: Thromboembolic complications are a leading cause of morbidity and mortality in patients with Fontan physiology. Current clinical practice for prevention and treatment of these complications involves the use of vitamin K antagonists and/or antiplatelet agents. Novel oral anticoagulants (